Daratumumab regimen keeps 81% of newly diagnosed transplant-eligible myeloma patients progression-Free at six years in PERSEUS update Medical Daily 2d Medical Daily 2d
IMS26: Key readouts rock the multiple myeloma field amid shifting landscape Clinical Trials Arena 4d Clinical Trials Arena 4d
Exploring the shifting treatment paradigm for smoldering multiple myeloma Hematology Advisor 7d Hematology Advisor 7d
Two Falls Seemed to Explain a 77-Year-Old's Brain Scan, but Surgery Uncovered a Rare Lymphoma Instead Medical Daily 05:01
Promising Results With Anti-BCMA/GPRC5D CAR-T in RRMM With Extraosseous EMD Oncology Nurse Advisor 14:14 Thu, 01 Oct
[Interview] Ewha Mokdong builds its next decade around women's cancer, urology, blood cancer Korea Biomedical Review 08:19 Thu, 01 Oct
Novel CAR-T therapy for hard-to-treat multiple myeloma shows promising safety and durable responses Newswise (Press Release) 22:04 Wed, 30 Sep
Treatment Strategies for Richter's Transformation to DLBCL Are Evolving Medpage Today 17:43 Wed, 30 Sep